The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

被引:61
|
作者
Mooradian, AD
Haas, MJ
Wong, NCW
机构
[1] St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63104 USA
[2] Univ Calgary, Dept Med & Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada
关键词
D O I
10.1210/er.2005-0013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the factors contributing to the increased risk of developing premature atherosclerosis is low plasma concentrations of high-density lipoprotein (HDL) cholesterol (HDLc). Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein A-I (apo A-I). The low plasma concentrations of HDL could be the result of increased fractional clearance and reduced expression of apo A-I. To this end, nutrients play an important role in modulating the fractional clearance rate, as well as the rate of apo A-I gene expression. Because medical nutrition therapy constitutes the cornerstone of management of dyslipidemias, it is essential to understand the mechanisms underlying the changes in HDL level in response to alterations in dietary intake. In this review, we will discuss the effect of select nutrients on serum HDLc and apo A-I levels. Specifically, we will review the literature on the effect of carbohydrates, fatty acids, and ketones, as well as some of the nutrient-related metabolites, such as glucosamine and the prostanoids, on apo A-I gene expression. Because there are multiple mechanisms involved in the regulation of serum HDLc levels, changes in gene transcription do not necessarily correlate with clinical observations on serum levels of HDLc.
引用
收藏
页码:2 / 16
页数:15
相关论文
共 50 条
  • [31] QUANTITATION OF APOLIPOPROTEIN A-I OF HUMAN-PLASMA HIGH-DENSITY LIPOPROTEIN
    ALBERS, JJ
    WAHL, PW
    CABANA, VG
    HAZZARD, WR
    HOOVER, JJ
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (06): : 633 - 644
  • [32] High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
    van der Steeg, Wim A.
    Holme, Ingar
    Boekholdt, S. Matthijs
    Larsen, Mogens Lytken
    Lindahl, Christina
    Stroes, Erik S. G.
    Tikkanen, Matti J.
    Wareham, Nicholas J.
    Faergeman, Ole
    Olsson, Anders G.
    Pedersen, Terje R.
    Khaw, Kay-Tee
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (06) : 634 - 642
  • [33] Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs
    Briand, F
    Magot, T
    Krempf, M
    Nguyen, P
    Ouguerram, K
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) : 224 - 230
  • [34] DEFINED APOLIPOPROTEIN A-I CONFORMATIONS IN RECONSTITUTED HIGH-DENSITY LIPOPROTEIN DISKS
    JONAS, A
    KEZDY, KE
    WALD, JH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (09) : 4818 - 4824
  • [35] Apolipoprotein A-I and high-density lipoprotein - Is this the beginning of the era of noninvasive angioplasty?
    Ballantyne, CM
    Nambi, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (07) : 1436 - 1438
  • [36] DISSOCIATION OF APOLIPOPROTEIN A-I FROM HUMAN HIGH-DENSITY LIPOPROTEIN PARTICLES
    FAINARU, M
    EISENBERG, S
    ARTERY, 1977, 3 (05) : 472 - 488
  • [37] Relationship of high-density lipoprotein subfractions and apolipoprotein A-I with fat in the pancreas
    Liu, Yutong
    Shamaitijiang, Xiatiguli
    Skudder-Hill, Loren
    Kimita, Wandia
    Sequeira-Bisson, Ivana R.
    Petrov, Maxim S.
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 123 - 133
  • [38] Differential impact of glycation on apolipoprotein A-I of high-density lipoprotein: a review
    Maarfi, Farah
    Ahmad, Saheem
    Alouffi, Sultan
    Akasha, Rihab
    Khan, M. Salman
    Rafi, Zeeshan
    Basnet, Hemashri
    Khan, Mohd Yasir
    GLYCOBIOLOGY, 2023, 33 (06) : 442 - 453
  • [39] Comparison of High-Density Lipoprotein Cholesterol to Apolipoprotein A-I and A-II to Predict Coronary Calcium and the Effect of Insulin Resistance
    Martin, Seth S.
    Qasim, Atif N.
    Wolfe, Megan
    St Clair, Caitlin
    Schwartz, Stanley
    Iqbal, Nayyar
    Schutta, Mark
    Bagheri, Roshanak
    Mehta, Nehal N.
    Rader, Daniel J.
    Reilly, Muredach P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (03): : 393 - 398
  • [40] TRIPLE THERAPY WITH STATIN, FIBRATE (TRILIPIX) AND NIACIN RAISES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITHOUT CHANGING APOLIPOPROTEIN A-I LEVELS
    Dunbar, Richard L.
    Gadi, Ramprasad
    Baer, Amanda
    Gupta, Ashwani
    Javed, Arshad
    Lord, Christine
    Rader, Daniel J.
    Millar, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)